uremic pruritus. Other disorders of the skin and subcutaneous tissue
Conditions
Interventions
Intervention 1: Control group: The non-thermal therapy group received drug therapy and routine care. The principal investigator stayed with these patients for the same duration as the thermal therapy
Treatment - Other
Control group: The non-thermal therapy group received drug therapy and routine care. The principal investigator stayed with these patients for the same duration as the thermal therapy group.
The intervention:
A system for thermal therapy was used for this study. A quiet and warm room with a far-infrared ray device was used and participants were placed in a supine position on a bed for 1
Sponsors
Deputy of Research and Technology of Shahed University;Elderly Research Center of Shahed University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria were: =18 years of age; able to communicate in persian; a diagnosis of uremia, confirmed in writing by the primary care physician; receiving haemodialysis three times a week for at least three months; having pruritus symptoms; being fully conscious. participants were excluded if they had any dermatological disorders; haematological disorders; organic problems or current use of drugs that might contradict or interfere with the assessments of outcomes; current requirement for haemodialysis more than three times per week due to comorbidity; Individuals who were unable or unwilling to follow the thermal therapy protocol for any reason were excluded from the trial
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uremic pruritus. Timepoint: Pre-Test:Before the intervention;Mid-Test:After 1 month from the beginning of the intervention.Post-Test:After two months and 18 sessions of heat therapy. Method of measurement: location and severity of uremic pruritus assessed by questionnaire and a visual analogue scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Life quality. Timepoint: Pre-Test:Before the intervention;Mid-Test:After 1 month from the beginning of the intervention.Post-Test:After two months and 18 sessions of heat therapy. Method of measurement: Assesed byquestionnaire(KDQOL- SF)Quality of life for patients with ESRD(Itchy Qol).;Biochemical indicators. Timepoint: Before thermal therapy 1 (pre-test), and middle thermal therapy 2 (mid-test),After thermal therapy 3 (post-test) months. Method of measurement: Secondary outcome measures included several biochemical indicators. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamedzare
shahed university
Outcome results
None listed